OBJECTIVE: The cocaine and amphetamine-regulated transcript (CART) is expressed in the brain of rodents and humans, and intracerebroventricular injection of the peptide in rats reduces food intake. The objective of the present study was to chromosomally map the CART gene and to examine the coding region of the gene for variability in obese subjects. METHODS: The coding region of the CART gene was analyzed by single-strand conformation polymorphism analysis in 84 subjects with early onset obesity. The prevalence of identified mutations was estimated in a cohort of 757 subjects with juvenile onset obesity [body mass index (BMI) = 35.7+/-5.7 kg/m2+/-standard deviation (S)] and in 890 random control subjects (BMI = 26.1+/-3.6 kg/m2+/-S). Furthermore, using radiation hybrid mapping we mapped the chromosomal localization of the human CART gene. RESULTS: Radiation hybrid mapping co-localized the CART gene with a recently published human obesity locus at chromosome 5q13-14 corresponding also to an obesity locus at the similar syntenic region in mice. We identified two silent polymorphisms in the 3'UTR region of the gene (position 1457 deletion of A and position 1475 A-->G substitution) and the prevalence of these was determined among obese and control subjects. However, none of the variants were associated with either obesity or weight gain during an average follow-up period of 27.4+/-8.4 years (S). CONCLUSION: Mutations in the coding region of the CART gene are unlikely to be involved in body weight control in Danish Caucasians with early onset obesity.
OBJECTIVE: The cocaine and amphetamine-regulated transcript (CART) is expressed in the brain of rodents and humans, and intracerebroventricular injection of the peptide in rats reduces food intake. The objective of the present study was to chromosomally map the CART gene and to examine the coding region of the gene for variability in obese subjects. METHODS: The coding region of the CART gene was analyzed by single-strand conformation polymorphism analysis in 84 subjects with early onset obesity. The prevalence of identified mutations was estimated in a cohort of 757 subjects with juvenile onset obesity [body mass index (BMI) = 35.7+/-5.7 kg/m2+/-standard deviation (S)] and in 890 random control subjects (BMI = 26.1+/-3.6 kg/m2+/-S). Furthermore, using radiation hybrid mapping we mapped the chromosomal localization of the humanCART gene. RESULTS: Radiation hybrid mapping co-localized the CART gene with a recently published humanobesity locus at chromosome 5q13-14 corresponding also to an obesity locus at the similar syntenic region in mice. We identified two silent polymorphisms in the 3'UTR region of the gene (position 1457 deletion of A and position 1475 A-->G substitution) and the prevalence of these was determined among obese and control subjects. However, none of the variants were associated with either obesity or weight gain during an average follow-up period of 27.4+/-8.4 years (S). CONCLUSION: Mutations in the coding region of the CART gene are unlikely to be involved in body weight control in Danish Caucasians with early onset obesity.
Authors: Ching-Yu Cheng; W H Linda Kao; Nick Patterson; Arti Tandon; Christopher A Haiman; Tamara B Harris; Chao Xing; Esther M John; Christine B Ambrosone; Frederick L Brancati; Josef Coresh; Michael F Press; Rulan S Parekh; Michael J Klag; Lucy A Meoni; Wen-Chi Hsueh; Laura Fejerman; Ludmila Pawlikowska; Matthew L Freedman; Lina H Jandorf; Elisa V Bandera; Gregory L Ciupak; Michael A Nalls; Ermeg L Akylbekova; Eric S Orwoll; Tennille S Leak; Iva Miljkovic; Rongling Li; Giske Ursin; Leslie Bernstein; Kristin Ardlie; Herman A Taylor; Eric Boerwinckle; Joseph M Zmuda; Brian E Henderson; James G Wilson; David Reich Journal: PLoS Genet Date: 2009-05-22 Impact factor: 5.917
Authors: Audrey Guérardel; Mouna Barat-Houari; Francis Vasseur; Christian Dina; Vincent Vatin; Karine Clément; Delphine Eberlé; Valérie Vasseur-Delannoy; Christopher G Bell; Pilar Galan; Serge Hercberg; Nicole Helbecque; Natascha Potoczna; Fritz F Horber; Philippe Boutin; Philippe Froguel Journal: BMC Genet Date: 2005-04-11 Impact factor: 2.797